Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Dirnhofer

Showing results (11-20 of 155) with videos related to

Pageof 16
Sort By:
Human Pathology|August 22, 2009
Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survivalSimone Muenst, Sylvia Hoeller, Stephan Dirnhofer, et al.
Experimental Gerontology|August 30, 2005
Tissue microarray technology: principles, pitfalls and perspectives--lessons learned from hematological malignanciesAlexandar Tzankov, Philip Went, Annette Zimpfer, et al.
Acta Haematologica|April 30, 2002
Idiopathic myelofibrosis with nodal, serosal and parenchymatous infiltration. Case report and review of the literatureAlexander Tzankov, Jens Krugmann, Michael Steurer, et al.
BMC Clinical Pathology|June 7, 2013
Relapsed angioimmunoblastic T-cell lymphoma with acquired expression of CD20: a case report and review of the literatureYara Banz, Fatime Krasniqi, Stephan Dirnhofer, et al.
Pathology, Research and Practice|April 26, 2008
Cytokeratin expression in hematological neoplasms: a tissue microarray study on 866 lymphoma and leukemia casesHeiner Adams, Patrik Schmid, Stephan Dirnhofer, et al.
The American Journal of Surgical Pathology|April 12, 2014
Clinical, morphologic, phenotypic, and genetic evidence of cyclin D1-positive diffuse large B-cell lymphomas with CYCLIN D1 gene rearrangementsDarius Juskevicius, Christian Ruiz, Stephan Dirnhofer, et al.
Expert Opinion on Investigational Drugs|January 6, 2011
Targetable molecular pathways in classical Hodgkin's lymphomaHeiner Adams, Ellen C Obermann, Stephan Dirnhofer, et al.
Human Pathology|April 6, 2016
Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomasThomas Menter, Andrea Bodmer-Haecki, Stephan Dirnhofer, et al.
Experimental Hematology|October 28, 2009
Coexpression of CD44 variant isoforms and receptor for hyaluronic acid-mediated motility (RHAMM, CD168) is an International Prognostic Index and C-MYC gene status-independent predictor of poor outcome in diffuse large B-cell lymphomasSabine Nagel, Petra Hirschmann, Stephan Dirnhofer, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 10, 2014
Diagnostic Utility of the Germinal Center-associated Markers GCET1, HGAL, and LMO2 in Hematolymphoid NeoplasmsThomas Menter, Anjes Gasser, Darius Juskevicius, et al.
Pageof 16

Showing results (11-20 of 155) with videos related to

Sort By:
Pageof 16
Human Pathology|August 22, 2009
Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survivalSimone Muenst, Sylvia Hoeller, Stephan Dirnhofer, et al.
Experimental Gerontology|August 30, 2005
Tissue microarray technology: principles, pitfalls and perspectives--lessons learned from hematological malignanciesAlexandar Tzankov, Philip Went, Annette Zimpfer, et al.
Acta Haematologica|April 30, 2002
Idiopathic myelofibrosis with nodal, serosal and parenchymatous infiltration. Case report and review of the literatureAlexander Tzankov, Jens Krugmann, Michael Steurer, et al.
BMC Clinical Pathology|June 7, 2013
Relapsed angioimmunoblastic T-cell lymphoma with acquired expression of CD20: a case report and review of the literatureYara Banz, Fatime Krasniqi, Stephan Dirnhofer, et al.
Pathology, Research and Practice|April 26, 2008
Cytokeratin expression in hematological neoplasms: a tissue microarray study on 866 lymphoma and leukemia casesHeiner Adams, Patrik Schmid, Stephan Dirnhofer, et al.
The American Journal of Surgical Pathology|April 12, 2014
Clinical, morphologic, phenotypic, and genetic evidence of cyclin D1-positive diffuse large B-cell lymphomas with CYCLIN D1 gene rearrangementsDarius Juskevicius, Christian Ruiz, Stephan Dirnhofer, et al.
Expert Opinion on Investigational Drugs|January 6, 2011
Targetable molecular pathways in classical Hodgkin's lymphomaHeiner Adams, Ellen C Obermann, Stephan Dirnhofer, et al.
Human Pathology|April 6, 2016
Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomasThomas Menter, Andrea Bodmer-Haecki, Stephan Dirnhofer, et al.
Experimental Hematology|October 28, 2009
Coexpression of CD44 variant isoforms and receptor for hyaluronic acid-mediated motility (RHAMM, CD168) is an International Prognostic Index and C-MYC gene status-independent predictor of poor outcome in diffuse large B-cell lymphomasSabine Nagel, Petra Hirschmann, Stephan Dirnhofer, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 10, 2014
Diagnostic Utility of the Germinal Center-associated Markers GCET1, HGAL, and LMO2 in Hematolymphoid NeoplasmsThomas Menter, Anjes Gasser, Darius Juskevicius, et al.
Pageof 16